Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter study

Authors:

Abstract
No abstract available
Funding Information
  • Roche
  • Sanofi Genzyme
  • Biogen
  • Cilag
  • Teva Pharmaceutical Industries
  • Austrian Science Fund (DOC 33-B27)
  • European Committee for Treatment and Research in Multiple Sclerosis
  • Novartis
  • Sandoz
  • GlaxoSmithKline
  • Merck
  • Bayer
  • UCB

This publication has 19 references indexed in Scilit: